Synapse - Shakeel Modak

Results (50)

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Journal Article

Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
OncoImmunology (2018)

Fulltext@MSK | Save

Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study

Journal Article

Friedman, D. N.; Hilden, P.; Moskowitz, C. S.; Wolden, S. L.; Tonorezos, E. S.; Antal, Z.; Carlow, D.; Modak, S.; Cheung, N. K.; Oeffinger, K. C.; more...
Pediatric Blood and Cancer (2018)

Fulltext@MSK | Save

Assessment of organ dosimetry for planning repeat treatments of high-dose (131)I-MIBG therapy: (123)I-MIBG versus posttherapy (131)I-MIBG imaging

Journal Article

Pandit-Taskar, N.; Zanzonico, P.; Hilden, P.; Ostrovnaya, I.; Carrasquillo, J. A.; Modak, S.
Clinical Nuclear Medicine (2017)

Fulltext@MSK | Save

Enrichment of targetable mutations in the relapsed neuroblastoma genome

Journal Article

Padovan-Merhar, O. M.; Raman, P.; Ostrovnaya, I.; Kalletla, K.; Rubnitz, K. R.; Sanford, E. M.; Ali, S. M.; Miller, V. A.; Mossé, Y. P.; Granger, M. P.; more...
PLoS Genetics (2016)

Fulltext@MSK | Save

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

Journal Article

Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Modak, S.; Kramer, K.; Roberts, S. S.; Basu, E. M.; Yataghene, K.; Cheung, N. K. V.
Oncotarget (2016)

Fulltext@MSK | Save

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: A prospective phase II study

Journal Article

Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Kramer, K.; Modak, S.; Yataghene, K.; Cheung, N. K. V.
OncoImmunology (2015)

Fulltext@MSK | Save

Osteochondroma in long-term survivors of high-risk neuroblastoma

Journal Article

Kushner, B. H.; Roberts, S. S.; Friedman, D. N.; Kuk, D.; Ostrovnaya, I.; Modak, S.; Kramer, K.; Basu, E. M.; Cheung, N. K. V.
Cancer (2015)

Fulltext@MSK | Save

Predictors of overall survival in patients diagnosed with desmoplastic small round cell tumor (DSRCT)

Meeting Abstract

Shoushtari, A. N.; Qin, L. X.; Kuk, D.; Magnan, H. D.; Modak, S.; Wolden, S. L.; Cho, E. J.; Pallos, V.; Grubman, O.; Viny, A. D.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?

Journal Article

Cheung, N. K. V.; Modak, S.; Ostrovnaya, I.; Roberts, S. S.; Basu, E. M.; Kramer, K.; Kushner, B. H.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Key role for myeloid cells: Phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma

Journal Article

Cheung, N. K. V.; Cheung, I. Y.; Kramer, K.; Modak, S.; Kuk, D.; Pandit-Taskar, N.; Chamberlain, E.; Ostrovnaya, I.; Kushner, B. H.
International Journal of Cancer (2014)

Fulltext@MSK | Save